Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By Marianne Chang Published: June 5, 2023, 8:32 p.m.· Tags: Vaccines
22 May 2023 -- Quratis said on Monday that the phase 2a clinical trial results of its novel tuberculosis (TB) vaccine for adults and adolescents, QTP101, showed excellent safety and immunogenicity.
Read More →
Page 1 of 1 · Total posts: 1
